Get started
Author

Yajing Du

The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies
2024 · Haochuan Guo, Xinru Xu, et al. · Pharmaceuticals · 67
PDF
Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer
2021 · Ming Li, Zhencong Chen, et al. · Journal of Cancer · 27
PDF
LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation
2021 · Qiongqiong Yu, Yajing Du, et al. · The Journal of Biochemistry · 14
Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs
2023 · Yajing Du, Lulu Luo, et al. · Pharmaceutics · 12
PDF
LncRNA TUG1 positively regulates osteoclast differentiation by targeting v-maf musculoaponeurotic fibrosarcoma oncogene homolog B
2020 · Ya-jing Du, Qiong-qiong Yu, et al. · Autoimmunity · 12
Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
2020 · Yajing Du, Shali Shao, et al. · Frontiers in Oncology · 12
PDF
Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma
2020 · Zhengyang Hu, Guoshu Bi, et al. · International Immunopharmacology · 11
Relationship between smoking and lung cancer cell type
1991 · Y.X. Du, Q. Cha, et al. · Lung Cancer · 11
Multi-omics characterization and validation of MSI-related molecular features across multiple malignancies
2021 · Yuansheng Zheng, Yiwei Huang, et al. · Life Sciences · 10
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression
2023 · Xinbing Yang, Yajing Du, et al. · International Journal of Molecular Sciences · 9
PDF
Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I–IIIA non-small cell lung cancer: a propensity-matched analysis
2020 · Junjie Xi, Yajing Du, et al. · Journal of Thoracic Disease · 9
PDF
Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index
2021 · Yajing Du, Sujuan Yuan, et al. · Disease Markers · 8
PDF
Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients
2024 · Minghe Lv, Shali Shao, et al. · Journal of Lipids · 7
PDF
Pain sensitivity and quality of life of patients with burning mouth syndrome: a preliminary study in a Chinese population
2023 · Hongsen Zhao, Shujun Ran, et al. · BMC Oral Health · 5
PDF
Promising Stereotactic Body Radiotherapy in NSCLC
2020 · Yajing Du, Cheng Zhan, et al. · Journal of Thoracic Oncology · 4
PDF
CDK9 inhibitor elicits APC through a synthetic lethal effect in colorectal cancer cells
2024 · Tingming Liang, Lulu Luo, et al. · Genes & Diseases · 2
Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma
2023 · Yuan Qu, Shan Xue, et al. · Oncology Letters · 2
PDF
Noncancer Cells in Tumor Samples May Bias the Predictive Genomic-Adjusted Radiation Dose
2021 · Yajing Du, Zhengyang Hu, et al. · Journal of Thoracic Oncology · 2
PDF
Orchestrating Cellular Balance: ncRNAs and RNA Interactions at the Dominant of Autophagy Regulation in Cancer
2024 · Xueni Yang, Shizheng Xiong, et al. · International Journal of Molecular Sciences · 1
PDF
Genome-wide analyses of lung cancer after single high-dose radiation at five time points (2, 6, 12, 24, and 48 h)
2023 · Yajing Du, Yunna Zheng, et al. · Frontiers in Genetics · 1
[Skeletal Class Ⅲ patients treated with Fränkel function regulator type Ⅲ in the early and late mixed dentition].
2016 · Yajing Du, Shiyan Huang, et al. · PubMed · 1
TNIK knockdown reverses 5-fluorouracil resistance in colorectal cancer via modulation of the Wnt/β-catenin signaling pathway
2026 · Tingming Liang, Yajing Du, et al. · Genes & Diseases
PDF
ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma
2026 · Yajing Du, Qiongqiong Yu · Annals of Surgical Oncology
PDF
Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma
2026 · Yajing Du, Qiongqiong Yu · Annals of Surgical Oncology
Submental island flap reconstruction in the era of neoadjuvant immunochemotherapy: a propensity score-matched cohort study in oral squamous cell carcinoma
2026 · Yajing Du, Qiongqiong Yu · BMC Oral Health
Works count: 32
Citation count: 227
H-index: 9
I10-index: 9
Year
Topic
Type